This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39: 699-706. 10.1111/j.1365-2362.2009.02162.xGuthSTheuneUAberleJGalachABambergerCM.Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination20093969970610.1111/j.1365-2362.2009.02162.x19601965Open DOISearch in Google Scholar
Jiang H, Tian Y, Yan W, Kong Y, Wang H, Wang A, et al. The prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities. Int J Environ Res Public Health 2016; 13: 1-11. 10.3390/ijerph13040442JiangHTianYYanWKongYWangHWangAThe prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities20161311110.3390/ijerph13040442484710427110805Open DOISearch in Google Scholar
Remonti LR, Kramer CK, Leitao CB, Pinto LCF, Gross JL. Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid 2015; 25: 538-50. 10.1089/thy.2014.0353RemontiLRKramerCKLeitaoCBPintoLCFGrossJL.Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies2015255385010.1089/thy.2014.0353444713725747526Open DOISearch in Google Scholar
Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006; 91: 3411-17. 10.1210/jc.2006-0690FratesMCBensonCBDoubiletPMKunreutherEContrerasMCibasESPrevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography20069134111710.1210/jc.2006-069016835280Open DOISearch in Google Scholar
Welker MJ, Orlov D. Thyroid nodules. Am Fam Physician 2003; 67: 559-66; 573.WelkerMJOrlovD.Thyroid nodules20036755966573Search in Google Scholar
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29. 10.3322/caac.21208SiegelRMaJZouZJemalA.Cancer statistics, 201420146492910.3322/caac.2120824399786Open DOISearch in Google Scholar
Crowe A, Linder A, Hameed O, Salih C, Roberson J, Gidley J, et al. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, ‘risk’ of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions. Cancer Cytopathol 2011; 119: 315-21. 10.1002/cncy.20174CroweALinderAHameedOSalihCRobersonJGidleyJThe impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, ‘risk’ of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions20111193152110.1002/cncy.2017421751427Open DOISearch in Google Scholar
Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. J Am Soc Cytopathol 2017; 6: 217-22. 10.1016/j.jasc.2017.09.002CibasESAliSZ.The 2017 Bethesda System for Reporting Thyroid Cytopathology201762172210.1016/j.jasc.2017.09.00231043290Open DOISearch in Google Scholar
Gweon HM, Son EJ, Youk JH, Kim JA. Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step? Ann Surg Oncol 2013; 20: 3083-8. 10.1245/s10434-013-2990-xGweonHMSonEJYoukJHKimJA.Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?2013203083810.1245/s10434-013-2990-x23700214Open DOISearch in Google Scholar
Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014; 24: 832-9. 10.1089/thy.2013.0317HoASSartiEEJainKSWangHNixonIJShahaARMalignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)201424832910.1089/thy.2013.0317494820624341462Open DOISearch in Google Scholar
Ryu YJ, Jung YS, Yoon HC, Hwang MJ, Shin SH, Cho JS, et al. Atypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy. Ann Surg Treat Res 2014; 86: 109. 10.4174/astr.2014.86.3.109RyuYJJungYSYoonHCHwangMJShinSHChoJSAtypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy20148610910.4174/astr.2014.86.3.109399462424761418Open DOISearch in Google Scholar
Jeong SH, Sook HH, Lee EH. Outcome of Bethesda III thyroid nodules and its correlation with ultrasonographic features and BRAF. Poster presented at European Congress of Radiology; 2013 March 7-11; Vienna, Austria. No. C-0842. 10.1594/ecr2013/C-0842JeongSHSookHHLeeEH.Outcome of Bethesda III thyroid nodules and its correlation with ultrasonographic features and BRAF2013March 7-11Vienna, AustriaC-084210.1594/ecr2013/C-0842Open DOISearch in Google Scholar
Yoo MR, Gweon HM, Park AY, Cho KE, Kim J, Youk JH, et al. Repeat diagnoses of Bethesda category III thyroid nodules: what to do next? PLoS One 2015; 10: 1-10. 10.1371/journal.pone.0130138YooMRGweonHMParkAYChoKEKimJYoukJHRepeat diagnoses of Bethesda category III thyroid nodules: what to do next?20151011010.1371/journal.pone.0130138448268426115096Open DOISearch in Google Scholar
Nagarkatti SS, Faquin WC, Lubitz CC, Garcia DM, Barbesino G, Ross DS, et al. The management of thyroid nodules with atypical cytology on fine needle aspiration biopsy. Ann Surg Oncol 2013; 20: 1-13. 10.1245/s10434-012-2601-2NagarkattiSSFaquinWCLubitzCCGarciaDMBarbesinoGRossDSThe management of thyroid nodules with atypical cytology on fine needle aspiration biopsy20132011310.1245/s10434-012-2601-2386691122941160Open DOISearch in Google Scholar
Vanderlaan PA, Marqusee E, Krane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 2011; 136: 572-7. 10.1309/AJCPO0BQ2YSKPXXPVanderlaanPAMarquseeEKraneJF.Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance2011136572710.1309/AJCPO0BQ2YSKPXXP21917679Open DOISearch in Google Scholar
Godazandeh G, Kashi Z, Zargamataj S, Fazli M, Ebadi R, Kerdabadi EH, et al. Evaluation the relationship between thyroid nodule size with malignancy and accuracy of fine needle aspiration biopsy (FNAB). Acta Inform Medica 2016; 24: 347-51. 10.5455/aim.2016.24.347-351GodazandehGKashiZZargamatajSFazliMEbadiRKerdabadiEHEvaluation the relationship between thyroid nodule size with malignancy and accuracy of fine needle aspiration biopsy (FNAB)2016243475110.5455/aim.2016.24.347-351Open DOISearch in Google Scholar
McHenry CR, Huh ES, Machekano RN. Is nodule size an independent predictor of thyroid malignancy? Surgery 2018; 144: 1062-9. 10.1016/j.surg.2008.07.021McHenryCRHuhESMachekanoRN.Is nodule size an independent predictor of thyroid malignancy?20181441062910.1016/j.surg.2008.07.02119041019Open DOISearch in Google Scholar
Kamran SC, Marqusee E, Kim M, Frates M, Ritner J, Peters H, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab 2013; 98: 564-70. 10.1210/jc.2012-2968KamranSCMarquseeEKimMFratesMRitnerJPetersHThyroid nodule size and prediction of cancer2013985647010.1210/jc.2012-296823275525Open DOISearch in Google Scholar
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133. 10.1089/thy.2015.0020HaugenBRAlexanderEKBibleKCDohertyGMMandelSJNikiforovYE2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer201626113310.1089/thy.2015.0020473913226462967Open DOISearch in Google Scholar
Mirfakhraee S, Mathews D, Peng L, Woodruff S, Zigman JM. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res 2013; 6: 7. 10.1186/1756-6614-6-7MirfakhraeeSMathewsDPengLWoodruffSZigmanJM.A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature20136710.1186/1756-6614-6-7365591923641736Open DOISearch in Google Scholar
Kwak JY. Indications for fine needle aspiration in thyroid nodules. Endocrinol Metab 2013; 28: 81-5. 10.3803/EnM.2013.28.2.81KwakJY.Indications for fine needle aspiration in thyroid nodules20132881510.3803/EnM.2013.28.2.81381171924396658Open DOISearch in Google Scholar
Lingam RK, Qarib MH, Tolley NS. Evaluating thyroid nodules: Predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology. Insights Imaging 2013; 4: 617-24. 10.1007/s13244-013-0256-6LingamRKQaribMHTolleyNS.Evaluating thyroid nodules: Predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology201346172410.1007/s13244-013-0256-6Open DOISearch in Google Scholar
Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK, Kwak JY, et al. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 2011; 12: 1-14. 10.3348/kjr.2011.12.1.1MoonWJBaekJHJungSLKimDWKimEKKwakJYUltrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations20111211410.3348/kjr.2011.12.1.1Open DOISearch in Google Scholar
Khadra H, Bakeer M, Hauch A, Hu T, Kandil E. Is vascular flow a predictor of malignant thyroid nodules? A meta-analysis. Gland Surg 2016; 5: 576-82. 10.21037/gs.2016.12.14KhadraHBakeerMHauchAHuTKandilE.Is vascular flow a predictor of malignant thyroid nodules? A meta-analysis201655768210.21037/gs.2016.12.14Open DOISearch in Google Scholar
Maia F, Zantut-Wittmann D. Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy. Clinics 2012; 67: 945-54. 10.6061/clinics/2012(08)15MaiaFZantut-WittmannD.Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy2012679455410.6061/clinics/2012(08)15Open DOISearch in Google Scholar
Ohori N, Nikiforova M, Schoedel K, Lebeau S, Hodak S, Seethala RR, et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of ‘follicular lesion of undetermined significance/atypia of undetermined significance’. Cancer Cytopathol 2010; 118: 17-23. 10.1002/cncy.20063OhoriNNikiforovaMSchoedelKLebeauSHodakSSeethalaRRContribution of molecular testing to thyroid fine-needle aspiration cytology of ‘follicular lesion of undetermined significance/atypia of undetermined significance’2010118172310.1002/cncy.2006320099311Open DOISearch in Google Scholar
Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009; 94: 2092-8. 10.1210/jc.2009-0247NikiforovYEStewardDLRobinson-SmithTMHaugenBRKlopperJPZhuZMolecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules2009942092810.1210/jc.2009-024719318445Open DOISearch in Google Scholar
Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, et al. Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis. Onco Targets Ther 2016; 9: 2495-509. 10.2147/OTT.S101800SuXJiangXXuXWangWTengXShaoADiagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis20169249550910.2147/OTT.S101800485426827175084Open DOISearch in Google Scholar